Focuses on the presence of ovarian cancer in Canada. How ovarian tumors develop; Statistics; Clinical management; Prevention; Where to go for further information.MoloughneyBrentSniderJudyVilleneuveLauraCMAJ: Canadian Medical Association JournalMoloughney B, Snider J, Villeneuve L: Ovarian cancer in ...
Public health aspects of breast cancer gene testing in Canada. Part 1: risks and interventions. The risks (penetrance) of breast and ovarian cancer in carriers of the BRCA1 or BRCA2 genes are high, but it is likely that estimates based on selected large multicase families are inflated by ...
Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada - Clinical ... S F,Dent,Klaassen,... - 《Annals of Oncology Official Journal of the European Society for Medical Oncology》 被引量: 53发表: 2000年...
distribution of cell type weights for non-malignant cell types exhibited notable heterogeneity both between and within samples (Supplementary Fig.S3). Similar results were obtained when we repeated the RCTD spot decomposition using a larger recently published metastatic ovarian cancer scRNA-seq dataset24....
Apart from metabolic diseases, obesity also causes multisystem complications in females, including cardiovascular diseases, stroke, endometrial cancer, infertility, and polycystic ovarian syndrome (PCOS) [5]. Obesity stands as a primary risk factor that detrimentally affects women’s reproductive health. ...
AVenn diagram showing the overlap of ChIP-seq peaks of PAX8 and PRDM3 in ovarian cancer cells. ***P < 0.001 represents the statistical significance of the overlap between PAX8 and PRDM3 using Fisher’s exact test.B(Top) Sequence logo representation of the top motif identified by de ...
“Now in its third year, World Ovarian Cancer Day has grown globally to over 78 organizations from 25 countries,” says Elisabeth Baugh, chair of the WOCD international organizing committee and CEO ofOvarian Cancer Canada. “In celebrating the unique bonds of women, we are acknowledging the str...
Ovarian Cancer Canada is the only national organization in Canada championing the health and wellbeing of women with and at risk for OC while advancing research to save lives [9]. The key pillars of our work include research, advocacy and support to women living with, or at risk of, the ...
Pater, J.; Quality of Life Committee of the NCIC CTG. Analysis and interpretation of health-related quality-of-life data from clinical trials: Basic approach of The National Cancer Institute of Canada Clinical Trials Group.Eur. J. Cancer2005,41, 280–287. [Google Scholar] [CrossRef] [PubMe...
Inc., Kenilworth, NJ, US, known as MSD outside the United States and Canada, announced a global strategic oncology collaboration to co-develop and co-commercialize LYNPARZA, the world’s first PARP inhibitor, an...